Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Prostatic Neoplasms 11Osteoporosis 8Vitamin D Deficiency 7Polycystic Ovary Syndrome 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Colonic Neoplasms 5Obesity 3Neoplasms 3Neoplasm Metastasis 3Lung Neoplasms 3Inflammation 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Bone Diseases, Metabolic 3Multiple Endocrine Neoplasia Type 1 2Motor Activity 2Lymphoma 2Leukemia 2Leiomyoma 2Giant Cell Tumor of Bone 2Gastrointestinal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Bone Diseases 2Warts 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Vitamin D 1Therapeutics 1Proton Pump Inhibitors 1Probiotics 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Helicobacter Infections × Vitamin D × Clear all
NCT07293910 2026-02-13

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

Tanta University

Phase 2 Recruiting
66 enrolled

Helicobacter Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡